Company: IMNN
Filing Date: 2025-12-31
Form Type: 424B5
Source: 0001493152-25-029712
Chunk: 30

Company: Imunon, Inc.
Filing Date: 2025-12-31
Form: 424B5
Chunk 30
---
 to any series of preferred stock issued by us. The rights, preferences, privileges and restrictions of the preferred stock of each series will be fixed by the certificate of designation relating to that series.

We currently have no shares of preferred stock outstanding. Our Board has the authority, without further action by the stockholders, to issue up to 100,000 shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions granted to or imposed upon the preferred stock. Any or all of these rights may be greater than the rights of our common stock.

Our Board, without stockholder approval (unless such stockholder action is required by applicable law or Nasdaq rules), can designate and issue shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the designations, powers (including voting), privileges, preferences and relative participating, optional or other rights, if any, of the shares of each such series, the qualifications, limitations or restrictions thereof, and to increase or decrease the number of shares of any such series, but not below the number of shares of such series then outstanding. Additionally, the issuance of preferred stock may have the effect of decreasing the market price of our common stock.

Our Board may specify the following characteristics of any preferred stock:

| ● | the                       
 maximum number of shares; |

| ● | the                        
 designation of the shares; |

| ● | the                                                                                          
 annual dividend rate, if any, whether the dividend rate is fixed or variable, the date or    
 dates on which dividends will accrue, the dividend payment dates, and whether dividends will 
 be cumulative;                                                                               |

| ● | the                                                                                           
 price and the terms and conditions for redemption, if any, including redemption at the option 
 of us or at the option of the holders, including the time period for redemption, and any      
 accumulated dividends or premiums;                                                            |

| ● | the                                                                                             
 liquidation preference, if any, and any accumulated dividends upon the liquidation, dissolution 
 or winding up of our affairs;                                                                   |

| ● | any                                                                                             
 sinking fund or similar provision, and, if so, the terms and provisions relating to the purpose 
 and operation of the fund;                                                                      |

| ● | the                                                                                          
 terms and conditions, if any, for conversion or exchange of shares of any other class or     
 classes of our capital stock or any series of any other class or classes, or of any other    
 series of the same class